Nuevos fármacos antirretrovirales: inhibidores del CCR5 y de la integrasa / New CCR5 inhibitor antiretroviral drugs and integrase inhibitors
Rev. clín. esp. (Ed. impr.)
; 208(9): 463-466, oct. 2008. ilus, tab
Article
en Es
| IBECS
| ID: ibc-71649
Biblioteca responsable:
ES15.1
Ubicación: ES15.1 - BNCS
ABSTRACT
Two new antiretroviral drugs belonging to a newdrug family have recently been marketed in Spain.These are maraviroc (CCR5 correceptor inhibitor)and raltegravir (integrase inhibitor). These have theadvantage of not presenting crossed resistance withother previously administered antiretroviral drugs,converting them into the cornerstone of the rescuetreatment in the patient infected by a multiresistantviral strain. The scientific evidence available onthese two drugs is reviewed in this work and its indications in the HIV infected patient are discussed (AU)
Buscar en Google
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Infecciones por VIH
/
Antirretrovirales
Límite:
Humans
Idioma:
Es
Revista:
Rev. clín. esp. (Ed. impr.)
Año:
2008
Tipo del documento:
Article